28th Apr 2014 16:31
LONDON (Alliance News) - The UK's blue-chip index closed modestly higher Monday, outperforming its smaller peers, after its sixth-largest constituent by market capitalisation, <strong>AstraZeneca</strong>, rose sharply after US drugs giant Pfizer Inc confirmed that it has now twice approached Read More